Roy A. Vallee's most recent trade in Synopsys, Inc. was a trade of 356 Common Stock done . Disclosure was reported to the exchange on April 10, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Synopsys | Roy A. Vallee | Director | 10 Apr 2024 | 356 | 2,622 (0%) | 0% | 0 | Common Stock | ||
| Synopsys | Roy A. Vallee | Director | 27 Feb 2024 | 10,000 | 20,000 (0%) | 0% | 572.7 | 5,726,595 | Common Stock | |
| Synopsys | Roy A. Vallee | Director | 12 Apr 2023 | 464 | 2,266 (0%) | 0% | 0 | Common Stock | ||
| Synopsys | Roy A. Vallee | Director | 23 Aug 2022 | 9,000 | 1,802 (0%) | 0% | 359.3 | 3,233,356 | Common Stock | |
| Synopsys | Roy A. Vallee | Director | 12 Apr 2022 | 563 | 10,802 (0%) | 0% | 0 | Common Stock | ||
| Synopsys | Roy A. Vallee | Director | 30 Aug 2021 | 10,000 | 30,000 (0%) | 0% | 334.0 | 3,339,964 | Common Stock | |
| Synopsys | Roy A. Vallee | Director | 08 Apr 2021 | 670 | 50,239 (0%) | 0% | 0 | Common Stock | ||
| Teradyne | Roy A. Vallee | Director | Sale of securities on an exchange or to another person at price $ 100.55 per share. | 11 Nov 2020 | 83,706 | 3,073 (0%) | 0% | 100.5 | 8,416,638 | Common Stock |